ArticleFrontiers in oncology2026

Serial assessment of inflammatory biomarkers as a prognostic factor for first-line treatment outcomes in patients with metastatic colorectal cancer: single-center retrospective study.

Nikša Librenjak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.